Richard Paulson

Richard Paulson - Ipsen US LeadershipChief Executive Officer, Ipsen North America

Since joining Ipsen in February 2018 as the North America Chief Executive Officer, Richard has been responsible for expanding and driving continued growth in both the U.S. and Canadian markets across key therapeutics areas of oncology, neuroscience and rare disease. Richard has more than 25 years of global biopharmaceutical industry experience with notable achievements for his leadership, vision, and exceptional execution in growing businesses, both in the US and internationally. He has a patient-focused mindset and a proven track record of successfully building high-performing, customer-centric teams. At Ipsen, Richard serves as a member of the Executive Leadership Team and chairs the Global Business Operations leadership team.

Prior to joining Ipsen, Richard had a 10-year career at Amgen where he held varying leadership positions across Europe and North America, including, Vice President and General Manager of Amgen’s U.S. Oncology Business Unit. Prior to that, he was the Vice President of Marketing for its U.S. Oncology Business, Vice President and General Manager of Amgen Germany, and General Manager of Amgen Central & Eastern Europe. Prior to joining Amgen, Richard held a number of global leadership positions at Pfizer Inc., including serving as General Manager of Pfizer South Africa and Pfizer Czech Republic as well as positions in marketing and market access. Richard also previously held a variety of sales, marketing, and market access roles with increasing seniority at GlaxoWellcome in Canada.

Richard serves as a member of the BIO Health Section Governing Board (HSGB), the Karyopharm Therapeutics Board, Boston Police Athletic League Board and as an interim director on the PhRMA Board of Directors.

Richard earned his undergraduate degree in Commerce from the University of Saskatchewan, Canada, and his MBA from the University of Toronto, Canada.

Our mission?

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products


Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2020 Ipsen Biopharmaceuticals, Inc. All rights reserved. June 2020 MP-US-000472